Aptevo Therapeutics Inc. (APVO) › Cost of RevenueAptevo Therapeutics Inc. (APVO) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2018: $11.21M2019: $19.93M$19.93M2018Cost of Revenue (USD)2019Fiscal YearCost of RevenueChange YoY2019$19.93M+77.7%2018$11.21M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share